165 related articles for article (PubMed ID: 2527155)
1. Additive effects of enoximone and nitroprusside in unstable chronic heart failure.
Treese N; Erbel R; Rhein S; Henrichs KJ; Meyer J
Eur Heart J; 1989 Jun; 10(6):484-92. PubMed ID: 2527155
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
[TBL] [Abstract][Full Text] [Related]
3. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside.
Herrmann HC; Ruddy TD; Dec GW; Strauss HW; Boucher CA; Fifer MA
Circulation; 1987 Jun; 75(6):1214-21. PubMed ID: 2952373
[TBL] [Abstract][Full Text] [Related]
4. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
5. Acute effects of enoximone in chronic heart failure.
Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487
[TBL] [Abstract][Full Text] [Related]
6. Long-term enoximone therapy in unstable chronic heart failure.
Treese N; Rhein S; Erbel R; Meyer J
J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S78-83. PubMed ID: 2480491
[TBL] [Abstract][Full Text] [Related]
7. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
[TBL] [Abstract][Full Text] [Related]
9. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure.
Amin DK; Shah PK; Hulse S; Shellock F
Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of MDL 17,043, a new cardiotonic agent, in patients with congestive heart failure: comparison with sodium nitroprusside.
Arbogast R; Brandt C; Haegele KD; Fincker JL; Schechter PJ
J Cardiovasc Pharmacol; 1983; 5(6):998-1004. PubMed ID: 6196573
[TBL] [Abstract][Full Text] [Related]
11. Addition of enoximone to adrenergic agents in the management of severe heart failure.
Vincent JL; Léon M; Berré J; Mélot C; Kahn RJ
Crit Care Med; 1992 Aug; 20(8):1102-6. PubMed ID: 1386567
[TBL] [Abstract][Full Text] [Related]
12. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment.
Dubourg O; Delorme G; Hardy A; Beauchet A; Tarral A; Bourdarias JP
Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
Gibelin P; Garraffo R; Sbirrazzuoli V; Lapalus P; Morand P
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():75-81. PubMed ID: 2147839
[TBL] [Abstract][Full Text] [Related]
14. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Saborowski F; Peters P; Schneider M
Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900
[TBL] [Abstract][Full Text] [Related]
15. Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
Weber KT; Janicki JS; Jain MC
Am J Cardiol; 1986 Sep; 58(7):589-95. PubMed ID: 2944369
[TBL] [Abstract][Full Text] [Related]
16. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
[TBL] [Abstract][Full Text] [Related]
17. [Acute effect of enoximone and captopril in patients with heart failure].
Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD
Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901
[TBL] [Abstract][Full Text] [Related]
18. Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure.
McDonald KM; O'Sullivan JJ; McWilliams EW; Conroy RC; Maurer BJ
Cardiovasc Drugs Ther; 1989 Dec; 3(6):913-8. PubMed ID: 2535057
[TBL] [Abstract][Full Text] [Related]
19. [Enoximone: hemodynamic effect in patients with cardiac insufficiency].
de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment with enoximone in patients referred for cardiac transplantation.
Coghlan JG; Norell M; Ilsley CD; Mitchell AG
Int J Cardiol; 1991 Jul; 32(1):57-63. PubMed ID: 1830866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
